Reversal effect of intra-central amygdala microinjection of L-arginine on place aversion induced by naloxone in morphine conditioned rats

Iranian Biomedical Journal

Volumn 15, Issue 3, 2011, Pages 92-99

  Karimi, Sara ^a   Karami, Manizheh ^a   Sahraei, Hedayat ^b   Rahimpour, Mahnaz ^a  

^a SHAHED UNIVERSITY   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

L arginine; L NAME; Morphine; Naloxone; Place aversion

Indexed keywords

ARGININE; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE;

ADULT ANIMAL; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HISTOLOGY; MALE; NONHUMAN; PLACE PREFERENCE; RAT; SYNTHESIS; TASK PERFORMANCE;

AMYGDALA; ANIMALS; ARGININE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROINJECTIONS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR;

EID: 82555188426     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Gutstein, H.B. and Akil, H. (2001) Opioid analgesics. In: Goodman and Gilman's the Pharmacological Basis of Therapeutics (Hardman, J.G., Limbird, L.E. and Goodman Gilman A. eds.), 10th ed. McGraw-Hill, New York, pp. 569-619.
2. McClung, C.A. (2006) The molecular mechanisms of morphine addiction. Rev. Neurosci. 17: 393-402.
3. Wise, R.A. (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend. 51: 13-22.
4. Ikemoto, S. (2007) Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 56: 27-78.
5. Di Chiara, G. and North, R.A. (1992) Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13: 185-193.
6. Tzschentke, T.M. (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 12: 227-462.
7. van der Kooy, D. (2007) Place conditioning: a simple and effective method for assessing the motivational properties of drugs. In: Methods of Assessing the Reinforcing Properties of Abused Drugs (Bozarth, M.A. ed.), Springer-Verlag, New York, pp. 229-240.
8. Di Chiara, G. and Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278.
9. Diaz, S.L., Barros, V.G., Antonelli, M.C., Rubio, M.C. and Balerio, G.N. (2006) Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice. Synapse. 60: 132-140.
10. Ishida, S., Shimosaka, R., Kawasaki, Y., Jin, C., Kitamura, Y., Araki, H., Sendo, T. and Gomit, Y. (2008) Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats. Yakugaku Zasshi 128: 395-403.
11. Wang, H-.Y., Friedman, E., Olmstead, M.C., Burns, L.H. (2005) Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling. Neuroscience 135: 247-261.
12. Olmstead, M.C. and Franklin, K.B. (1997) Development of a conditioned place preference to morphine: effects of lesions of various CNS sites. Behav. Neurosci. 111: 1313-1323.
13. Neisewander, J.L., Pierce, R.C. and Bardo, M.T. (1990) Naloxone enhances the expression of morphine-induced conditioned place preference. Psychopharmacology (Berl) 100: 201-205.
14. Fukuto, J.M. and Mayer, B. (1996) The enzymology of nitric oxide synthase. In: Methods in Nitric Oxide Research. (Feelisch, M. and Stamler, J.S. eds.), John Wiley & Sons Ltd., New York, pp. 147-157.
15. Garthwaite, J. (1991) Glutamate, nitric oxide and cellcell signaling in the nervous system. Trends Neurosci. 14: 60-67.
16. Moncada, S., Palmer, R.M.J. and Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142.
17. Kivastik, T., Rutkauskaite, J. and Zharkovsky, A. (1996) Nitric oxide synthesis inhibition attenuates morphineinduced place preference. Pharmacol. Biochem. Behav. 53: 1013-1015.
18. Zhu, W., Ma, Y., Bell, A., Esch, T., Guarna, M., Bilfinger, T.V., Bianchi, E. and Stefano, G.B. (2004) Presence of morphine in rat amygdala: evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures. Med. Sci. Monit. 10: BR433-439.
19. Paxinos, G. and Watson, C. (1987) The Rat Brain in Stereotaxic Coordinates. 2nd edition, Academic Press, Harcourt Brace Jovanovich Publisher, Ontario, Canada.
20. Overton, D.A. (1973) State-Dependent Learning Produced by Addicting Drugs. In: Opiate Addiction: Origin and Treatments (Fisher, S. and Freedman, A.M. eds.), Winston, Washington D.C., pp. 61-75.
21. Bie, B., Zhu, W. and Pan, Z.Z. (2005) Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses. J. Pharmacol. Exp.Ther. 329: 290-296.
22. Zhu, W. and Pan, Z.Z. (2009) Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 133: 97-103.
23. Heinmiller, A., Ting-A-Kee, R., Vargas-Perez, H., Yeh, A. and van der Kooy, D. (2009) Tegmental pedunculopontine glutamate and GABA-B synapses mediate morphine reward. Behav. Neurosci. 123: 145-155.
24. Skoubis, P.D., Matthes, H.W., Walwyn, W.M., Kieffer, B.L. and Maidment, N.T. (2001) Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice. Neuroscience 106: 757-763.
25. Phillips, A.G. and Le Piane, F.G. (1982) Reward produced by microinjection of (D-Ala2), Met5- enkephaline into the ventral tegmental area. Behav. Brain Res. 5: 225-229.
26. Bozarth, M.A. (1987) Conditioned Place Preference. A Parametric Analysis using Systemic Heroin Injections. In: Methods of Assessing the Reinforcing Properties of Abused Drugs (Bozarth, M.A. eds.), Springer-Verlag, New York, pp. 241-273.
27. Mucha, R.F. and Iversen, S.D. (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. Psychopharmacology (Berl) 82: 241-247.
28. Zarrindast, M.R., Faraji, N., Rostami, P., Sahraei, H. and Ghoshouni, H. (2003) Cross tolerance between morphine- and nicotine-induced conditioned place preferences in mice. Pharmacol. Biochem. Behav. 74: 363-369.
29. McBride, W.J., Murphy, J.M. and Ikemoto, S. (1999) Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place preference studies. Behav. Brain. Res. 101: 129-152.
30. Schulteis, C., Morse, A.C. and Liu, J. (2003) Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence. Pharmacol. Biochem. Behav. 76: 493-503.
31. Narita, M., Funada, M. and Suzuki, T. (2001) Regulations of opioid dependence by opioid receptor types. Pharmacol. Ther. 89: 1-15.
32. Le Guen, S., Gestreau, C. and Besson, J.M. (2003) Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system. Eur. J. Neurosci. 17: 2425-2437.
33. Zarrindast, M.R., Ebrahimi-Ghiri, M., Rostami, P. and Rezayof, A. (2007) Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms. Behav. Brain Res. 181: 35-41.
34. Cabral, A., Ruggiero, R.N., Nobre, M.J., Brandão, M.L. and Castilho, V.M. (2009) GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine. Prog. Neuropsychopharmacol. Biol Psychiatry 33: 334 344.
35. Chelarescu, D. and Nechifor, M. (2005) The method of conditioned place preference in pharmaco-dependence research. Rev. Med. Chir. Soc. Med. Nat. Iasi. 109: 355 359.
36. Vargas-Perez, H., Ting-A-Kee, R. and van der Kooy, D. (2009) Different neural systems mediate morphine reward and its spontaneous withdrawal aversion. Eur. J. Neurosci. 29: 2029-2034.